(-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4815-4822

  Sharma, Chhavi ^a   Nusri, Qurrat El Ain ^a   Begum, Salema ^a   Javed, Elham ^a   Rizvi, Tahir A ^b   Hussain, Arif ^a  

^a Manipal University   (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Cervical cancer; Epigallocatechin 3; Gallate; Invasion; Matrix metalloproteinases 9

Indexed keywords

EID: 84874012561     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4815     Document Type: Article

References (68)

1. Agarwal C, Sharma Y, Agarwal R (2000). Anticarcinogenic effect of a polyphenolic fraction isolated from grape seeds in human prostate carcinoma DU145 cells. modulation of mitogenic signaling and cell-cycle regulators and induction of G1 arrest and apoptosis. Mol Carcinog, 28, 129-38.
2. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H (1997). Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst, 89, 1881-6.
3. Artali R, Beretta G, Morazzoni P, Bombardelli E, Meneghetti F (2009). Green tea catechins in chemoprevention of cancer. a molecular docking investigation into their interaction with glutathione S-transferase (GST P1-1). J Enzyme Inhib Med Chem, 24, 287-95.
4. Aziz MH, Kumar R, Ahmad N (2003). Cancer chemoprevention by resveratrol. In vitro and in vivo studies and the underlying mechanisms. Int J Oncol, 23,17-28.
5. Baek SM, Kwon CH, Kim JH, et al (2003). Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med, 142, 178-86.
6. Bal DG, Foerster SB, Backman DR, Lyman DO (2001). Dietary change and cancer. challenges and future direction. J Nutr, 131,181-5.
7. Chan CM, Huang JH, Chiang HS, et al (2010). Effects of epigallocatechin gallate on RPE cell migration and adhesion. Molecular Vision, 16, 586-95.
8. Chen JJ, YE Z, Koo MWL (2004). Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBTII bladder tumor cell line. BJU International, 93,1082-6.
9. Clément MV, Hirpara JL, Chawdhury SH, Pervaiz S (1998). Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood, 92, 996-1002.
10. D'Agostini F, Izzotti A, Balansky RM, Bennicelli C, De Flora S (2005). Modulation of apoptosis by cancer chemopreventive agents. Mutat Res, 591,173-86.
11. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N (2000). Metalloproteinases. role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res, 2, 252-7.
12. Farabegoli F, Papi A, Orlandi M (2011). Epigallocatechin- 3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifenresistant cells. Biosci Rep, 31, 99-108.
13. Giannelli G, Antonaci S (2005). MMP and TIMP assay in cancer. Biological and clinical significance. Int J Cancer, 116, 1002-3.
14. Gomis-Rüth FX, Maskos K, Betz M, et al (1997). Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature, 389, 77-81.
15. Gu B, Ding Q, Xia G, Fang Z (2009). EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression. Oncol Rep, 21, 635-40.
16. Gupta S, Hussain T, Mukhtar H (2003). Molecular pathway for epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys, 410, 177-85.
17. Gupta S, Pramanik D, Mukherjee R, et al (2011). Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer. Clin Cancer Res, 11, 2165.
18. Harakeh S, Abu-El-Ardat K, Diab-Assaf M, et al (2008). Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and -negative leukemia cells. Med Oncol, 25,30-9.
19. Hibasami H, Achiwa Y, Fujikawa T, Komiya T (1996). Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds. Anticancer Res, 16, 1943-6.
20. Holten-Andersen MN, Murphy G, Nielsen HJ, et al (1999). Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer, 80, 495-503.
21. Hsu YC, Liou YM (2011). The anti-cancer effects of epigallocatechin-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells. J Cell Physiol, 226, 2721-30.
22. Huh SW, Bae SM, Kim YW, et al (2004). Anticancer effects of epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol, 94, 760-8.
23. Jones JL, Glynn P, Walker RA (1999). Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol, 189, 161-8.
24. Jung YD, Kim MS, Shin BA, et al (2001). EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer, 84, 844-50.
25. Kazi A, Smith DM, Zhong Q, Dou QP (2002). Inhibition of Bcl- XL Phosphorylation by Tea Polyphenols or Epigallocatechin- 3-Gallate Is Associated with Prostate Cancer Cell Apoptosis. Mol Pharmacol, 62, 765-71.
26. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H (2006). Targeting multiple signaling pathways by green tea polyphenol epigallocatechin-3-gallate. Cancer Res, 66, 2500-5.
27. Khuri FR, Kim ES, Lee JJ, et al (2001). The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev, 10, 823-9.
28. Kim C, Moon S (2005). Epigallocatechin-3-gallate causes the p21/WAF1-mediated G1-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF- a-induced vascular smooth muscle cells. Arch Biochem Biophy, 435, 264-72.
29. Kim HS, Kim MH, Jeong M, et al (2004). EGCG Blocks Tumor Promoter-induced MMP-9 Expression Via Suppression of MAPK and AP-1 Activation in Human Gastric AGS Cells. Anticancer Res, 24, 747-54.
30. Lambert E, Dasse E, Haye B, Petitfrere E (2004). TIMPs as multifacial proteins. Crit Rev Oncol Hematol, 49, 187-98.
31. Lambert JD, Yang CS (2003). Mechanisms of cancer prevention by tea constituents. J Nutr, 133, 3262-7.
32. Lee HS, Seo EY, Kang NE, Kim WK (2008). (6)-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem, 19, 313-9.
33. Li HC, Yashiki S, Sonoda J, et al (2000). Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T-cell leukemia patients. Jpn J Cancer Res, 91, 34-40.
34. Li Y, Che M, Bhagat S, et al (2004). Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia, 6, 354-63.
35. Liang YC, Lin-Shiau SY, Chen CF, Lin JK (1999). Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by epigallocatechin-3- gallate. J Cell Biochem, 75, 1-12.
36. Maeda-Yamamoto M, Suzuki N, Sawai Y, et al (2003). Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT 1080 cells. J Agric Food Chem, 51, 1858-63.
37. Matsuura N, Miyamae Y, Yamane K, et al (2006). Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. J Nutr, 136, 842-6.
38. Moongkarndi P, Kosem N, Kaslungka S, et al (2004). Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J Ethnopharmacol, 90, 161-6.
39. Park JH, Yoon JH, Kim SA, Ahn SG, Yoon JH (2010). Epigallocatechin-3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells. Oncol Rep, 23, 585-90.
40. Punathil T, Tollefsbol TO, Katiyar SK (2008). EGCG inhibits cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclise. Biochem Biophys Res Commun, 375, 162-7.
41. Qanungo S, Das M, Haldar S, Basu A (2005). Epigallocatechin- 3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis, 26, 958-67.
42. Qi W, Weber CR, Wasland K, Savkovic SD (2011). Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer, 11, 219.
43. Qiao Y, Cao J, Xie L, Shi X (2009). Cell growth inhibition and gene expression regulation by epigallocatechin-3- gallate in human cervical cancer cells. Arch Pharm Res, 32, 1309-15.
44. Rao SD, Pagidas K (2010). Epigallocatechin-3-gallate, a Natural Polyphenol, Inhibits Cell Proliferation and Induces Apoptosis in Human Ovarian Cancer Cells. Anticancer Res, 30, 2519-24.
45. Roomi MW, Monterrey JC, Kalinovsky T, Rath M, Niedzwiecki A (2010). Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines. Oncol Rep, 24, 747-57.
46. Roy M, Siddiqi M, Bhattacharya RK (2001). Cancer Chemoprevention. Tea Polyphenol Induced Cellular and Molecular Responses. Asian Pac J Cancer Prev, 2, 109-16.
47. Seeram NP, Henning SM, Niu Y, et al (2006). Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. J Agric Food Chem, 54, 1599-603.
48. Sen T, Chatterjee A (2011). Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells. involvement of integrin receptor aβ1 in the process. Eur J Nutr, 50, 465-78.
49. Sen T, Dutta A, Chatterjee A (2010). Epigallocatechin-3- gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. Anticancer Drugs, 21, 632-44.
50. Shankar S, Ganapathy S, Hingorani SR, Srivastava RK (2008). EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci, 13, 440-52.
51. Sharma C, Kaur J, Shishodia S, Aggarwal BB, Ralhan R (2006). Curcumin down regulates smokeless tobacco-induced NFkappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology, 228, 1-15.
52. Sharma C, Sadrieh L, Priyani A, et al (2011). Anti-carcinogenic effects of sulforaphane in association with its apoptosisinducing and anti-inflammatory properties in human cervical cancer cells. Cancer Epidemiol, 35, 272-8.
53. Shirakami Y, Shimizu M, Adachi S, et al (2009). Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis. Cancer Sci, 100, 1957-62.
54. Siddiqui IA, Malik A, Adhami VM, et al (2008). Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene, 27, 2055-63.
55. Sporn MB (1996). The war on cancer. Lancet, 347, 1377-81.
56. Sporn MB, Suh N(2000). Chemoprevention of cancer. Carcinogenesis, 21, 525-30.
57. Stingl JC, Ettrich T, Muche R, et al (2011). Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE). a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population. BMC Cancer, 11, 360.
58. Takada M, Nakamura Y, Koizumi T, et al (2002). Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas, 25, 45-8.
59. Takahashi H, Nomata K, Mori K, et al (2004). The preventive effect of green tea on the gap junction intercellular communication in renal epithelial cells treated with a renal carcinogen. Anticancer Res, 24, 3757-62.
60. Tang GQ, Yan TQ, Guo W, et al (2010). Epigallocatechin- 3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells. J Cancer Res Clin Oncol, 136, 1179-85.
61. Visse R, Nagase H (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases. structure, function, and biochemistry. Circ Res, 92, 827-39.
62. Wels J, Kaplan RN, Rafii S, Lyden D (2008). Migratory neighbors and distant invaders. tumor-associated niche cells. Genes Dev, 22, 559-74.
63. Yang CS, Maliakal P, Meng X (2002). Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol, 42, 25-54.
64. Yang G, Liao J, Kim K, Yurkow EJ, Yang CS (1998). Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis, 19, 611-6.
65. Zaveri NT (2006). Green tea and its polyphenolic catechins. Medicinal uses in cancer and noncancer applications. Life Sciences, 78, 2073-80.
66. Zhang W, Hashimoto K, Yu GY, Sakagami H (2002). Decline of superoxide dismutase activity during antioxidant-induced apoptosis in HL-60 cells. Anticancer Res, 22, 219-24.
67. Zhou F, Zhou H, Wang T, et al (2011). Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro. Acta Pharmacol Sin, 10, 139.
68. Zhu BH, Chen HY, Zhan WH, et al (2011). Epigallocatechin- 3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. World J Gastroenterol, 17, 2315-25.